Co-morbidities of HIV infection: role of Nef-induced impairment of cholesterol metabolism and lipid raft functionality.
: Combination anti-retroviral therapy (cART) has dramatically changed the outcome of HIV infection, turning it from a death sentence to a manageable chronic disease. However, co-morbidities accompanying HIV infection, such as metabolic and cardio-vascular diseases, as well as cognitive impairment, persist despite successful virus control by cART and pose considerable challenges to clinical management of people living with HIV (PLWH). These co-morbidities involve a number of pathological processes affecting a variety of different tissues and cells, making it challenging to identify a common cause(s) that would link these different diseases to HIV infection. In this article, we will present evidence that impairment of cellular cholesterol metabolism may be a common factor driving pathogenesis of HIV-associated co-morbidities. Potential implications for therapeutic approaches are discussed.